A detailed history of Comerica Bank transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Comerica Bank holds 108 shares of EWTX stock, worth $2,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108
Holding current value
$2,854
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$26.63 - $36.62 $2,876 - $3,954
108 New
108 $2,000
Q1 2024

May 15, 2024

BUY
$9.25 - $19.97 $527 - $1,138
57 New
57 $1,000

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.67B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.